In this issue, 1 review, 1 brief communication and 3 original articles have been published.
Alnaimat F, et al.
Reporting standards in health research have evolved, with initiatives like the Declaration of Helsinki, CONSORT, STROBE, and PRISMA enhancing transparency. AI, especially large language models like ChatGPT, have revolutionized academic writing by improving discoverability, facilitating statistical analysis, enhancing article quality, and reducing language barriers. However, the use of AI tools raises concerns about errors, transparency, biases, data limitations, and legal implications. Adjusting reporting rules to include AI tools is challenging. New checklists like METRICS and CLEAR have been introduced to promote transparency in AI studies. The study underscores the need for interdisciplinary collaboration and ethical assessment in using technology responsibly in research and writing.
Park HY, et al.
This study found that COVID-19 and delirium are independent risk factors for 1-year mortality. Among 832,602 individuals, including 416,301 COVID-19 patients, comorbidities, insurance type, and residence also influenced mortality. Antipsychotic use was linked to lower delirium incidence, while mood stabilizers and benzodiazepines were associated with higher delirium incidence. The findings suggest that some factors related to delirium in COVID-19 patients can be modified for preventive and therapeutic interventions.
Choi WS, et al.
This study followed COVID-19 patients for 18 months post-discharge, finding 31.0% had residual CT abnormalities. Lesion volume and forced vital capacity (FVC) improved between 6 and 18 months. Patients with CT abnormalities had lower FVC and higher SARS-CoV-2 IgG levels. Age was a significant predictor of CT abnormalities. The findings suggest ongoing monitoring and targeted interventions for these patients.
Park SH, et al.
The study evaluated long-term outcomes of Gamma Knife radiosurgery (GKS) for cerebral cavernous malformations (CCMs). It found that the annual hemorrhage rate (AHR) decreased significantly post-GKS. Most patients showed recovery and most lesions decreased in size. Previous hemorrhage history and brainstem location were significant risk factors for hemorrhage. The study concluded that GKS showed favorable long-term outcomes for CCM, especially for those with a previous hemorrhage history and brainstem location.
Kwon SL, et al.
In May 2024, South Korea ended its mpox alert. The Korea Disease Control and Prevention Agency (KDCA) led the response, focusing on diagnosis, investigations, treatment, and vaccination. Vaccination initially targeted high-risk groups, but expanded as cases increased. By April 2024, 6,863 people received their first vaccine dose, and 3,875 completed the second dose. Future response strategies include addressing stigma, securing representative safety data, and conducting vaccine cost-benefit analyses to ensure robust future outbreak responses.



PDF
Citation
Print



XML Download